Published in Heart Rhythm on March 07, 2008
Analysis of Left Atrial Respiratory and Cardiac Motion for Cardiac Ablation Therapy. Proc SPIE Int Soc Opt Eng (2015) 0.87
Assessment of left atrial volume and function: a comparative study between echocardiography, magnetic resonance imaging and multi slice computed tomography. Int J Cardiovasc Imaging (2011) 0.82
Navigated DENSE strain imaging for post-radiofrequency ablation lesion assessment in the swine left atria. Europace (2013) 0.77
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol (2004) 7.26
Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation (2000) 6.56
Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation (2003) 3.08
Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology (2007) 2.93
Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation (2000) 2.72
Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J (2005) 2.45
Validation of three-dimensional cardiac image integration: use of integrated CT image into electroanatomic mapping system to perform catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 2.30
Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol (1999) 2.24
Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol (1999) 1.89
Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electrophysiol (2004) 1.87
Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J (2007) 1.86
Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. Circulation (2006) 1.79
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol (2002) 1.74
Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm (2005) 1.70
Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: an echocardiography and cine computed tomography analysis. J Cardiovasc Electrophysiol (2006) 1.55
Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol (2004) 1.53
Assessment of left atrial volumes and phasic function using cine magnetic resonance imaging in normal subjects. Am J Cardiol (1994) 1.36
Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up. Pacing Clin Electrophysiol (2001) 1.18
Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol (2007) 1.00
Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure. J Am Coll Cardiol (2007) 0.98
Assessment of left atrial volume by contrast enhanced magnetic resonance angiography. J Cardiovasc Magn Reson (2004) 0.91
Nonfluoroscopic magnetic electroanatomic mapping to facilitate focal pulmonary veins ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (2002) 0.85
Novel method to integrate three-dimensional computed tomographic images of the left atrium with real-time electroanatomic mapping. J Cardiovasc Electrophysiol (2004) 0.83
Comparison of left atrial volume assessed by magnetic endocardial catheter mapping versus transthoracic echocardiography. Am J Cardiol (2003) 0.82
Functional disconnection of arrhythmogenic pulmonary veins in patients with paroxysmal atrial fibrillation guided by combined electroanatomical (CARTO) and conventional mapping. J Interv Card Electrophysiol (2002) 0.81
The effect of catheter ablation for atrial fibrillation on left atrial transport function. J Cardiovasc Electrophysiol (2006) 0.77
Utility of a nonfluoroscopic navigation system for pulmonary vein isolation. J Cardiovasc Electrophysiol (2004) 0.77
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87
Myocardial tissue tracking with two-dimensional cine displacement-encoded MR imaging: development and initial evaluation. Radiology (2004) 3.59
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson (2009) 3.17
An estimate of the global burden of anthropogenic ozone and fine particulate matter on premature human mortality using atmospheric modeling. Environ Health Perspect (2010) 3.17
Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. J Am Coll Cardiol (2009) 2.81
Elevated circulating fibrocyte levels in patients with hypertensive heart disease. J Hypertens (2012) 2.79
Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging (2012) 2.53
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging (2013) 2.02
Technology insight: in vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med (2006) 1.89
Imaging three-dimensional myocardial mechanics using navigator-gated volumetric spiral cine DENSE MRI. Magn Reson Med (2010) 1.78
Global air quality and health co-benefits of mitigating near-term climate change through methane and black carbon emission controls. Environ Health Perspect (2012) 1.77
MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magn Reson Med (2002) 1.77
Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol (2009) 1.71
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis (2011) 1.70
Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 1.69
Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68
Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation (2014) 1.67
Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease. J Am Coll Cardiol (2011) 1.58
Monocyte and/or macrophage infiltration of heart after myocardial infarction: MR imaging by using T1-shortening liposomes. Radiology (2012) 1.58
Image integration using intracardiac ultrasound and 3D reconstruction for scar mapping and ablation of ventricular tachycardia. J Cardiovasc Electrophysiol (2010) 1.56
Assessment of the accuracy and reproducibility of RV volume measurements by CMR in congenital heart disease. JACC Cardiovasc Imaging (2012) 1.54
Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first-pass contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging (2007) 1.54
Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol (2010) 1.53
Cost and yield of adding electrocardiography to history and physical in screening Division I intercollegiate athletes: a 5-year experience. Heart Rhythm (2010) 1.52
Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation. Heart Rhythm (2010) 1.50
Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot study. Vasc Med (2012) 1.48
Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging (2008) 1.48
Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology (2008) 1.48
MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics (2011) 1.48
Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2007) 1.40
High left ventricular mass index does not limit the utility of fractional flow reserve for the physiologic assessment of lesion severity. J Invasive Cardiol (2006) 1.40
Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol (2006) 1.35
Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J (2013) 1.31
Black blood gradient echo cine magnetic resonance imaging of the mouse heart. Magn Reson Med (2005) 1.28
Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation (2002) 1.28
Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Eur Heart J (2007) 1.26
Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J Roentgenol (2005) 1.26
Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping. J Magn Reson Imaging (2012) 1.19
Placement of transvenous pacemaker and ICD leads across total chronic occlusions. Pacing Clin Electrophysiol (2005) 1.18
Mechanisms of Post-Infarct Left Ventricular Remodeling. Drug Discov Today Dis Mech (2007) 1.16
ACR appropriateness criteria imaging for transcatheter aortic valve replacement. J Am Coll Radiol (2013) 1.15
Burden of disease attributed to anthropogenic air pollution in the United Arab Emirates: estimates based on observed air quality data. Sci Total Environ (2010) 1.15
Carotid artery calcification on CT may independently predict stroke risk. AJR Am J Roentgenol (2006) 1.14
Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging (2010) 1.14
Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. Am J Med (2012) 1.13
Reperfused myocardial infarction in mice: 3D mapping of late gadolinium enhancement and strain. J Cardiovasc Magn Reson (2006) 1.10
Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. Heart Rhythm (2005) 1.09
Improved arterial spin labeling after myocardial infarction in mice using cardiac and respiratory gated look-locker imaging with fuzzy C-means clustering. Magn Reson Med (2010) 1.07
Response to Van Koppen et al. J Hypertens (2013) 1.07
Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson (2004) 1.06
Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke. Circulation (2010) 1.06
Optimization of spiral-based pulse sequences for first-pass myocardial perfusion imaging. Magn Reson Med (2011) 1.05
Arterial spin labeling MR imaging reproducibly measures peak-exercise calf muscle perfusion: a study in patients with peripheral arterial disease and healthy volunteers. JACC Cardiovasc Imaging (2012) 1.04
Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force. J Am Coll Cardiol (2013) 1.04
Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. JACC Cardiovasc Imaging (2013) 1.03
Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT. J Interv Card Electrophysiol (2008) 1.02
MR cine DENSE dyssynchrony parameters for the evaluation of heart failure: comparison with myocardial tissue tagging. JACC Cardiovasc Imaging (2012) 1.02
Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs. J Nucl Cardiol (2012) 1.00
Relation of left atrial volume from three-dimensional computed tomography to atrial fibrillation recurrence following ablation. Am J Cardiol (2009) 0.99
Displacement-encoded and manganese-enhanced cardiac MRI reveal that nNOS, not eNOS, plays a dominant role in modulating contraction and calcium influx in the mammalian heart. Am J Physiol Heart Circ Physiol (2011) 0.99
T₂ -weighted MRI of post-infarct myocardial edema in mice. Magn Reson Med (2011) 0.98
Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting--initial experience. Radiology (2006) 0.96
Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial infarction. J Mol Cell Cardiol (2002) 0.95
Sonication of explanted cardiac rhythm management devices for the diagnosis of pocket infections and asymptomatic bacterial colonization. Pacing Clin Electrophysiol (2011) 0.95
Improved first-pass spiral myocardial perfusion imaging with variable density trajectories. Magn Reson Med (2012) 0.95
Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping. J Magn Reson Imaging (2013) 0.93
The prevalence of extracardiac findings by multidetector computed tomography before atrial fibrillation ablation. Am Heart J (2007) 0.92
2013 appropriate utilization of cardiovascular imaging: a methodology for the development of joint criteria for the appropriate utilization of cardiovascular imaging by the American College of Cardiology Foundation and American College of Radiology. J Am Coll Cardiol (2013) 0.92
Characterization of the mitral isthmus for atrial fibrillation ablation using intracardiac ultrasound from within the coronary sinus. Heart Rhythm (2007) 0.92
Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling. Hypertension (2004) 0.91
Cardiovascular magnetic resonance: structure, function, perfusion, and viability. J Nucl Cardiol (2005) 0.89
Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging (2008) 0.88
Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling. Am J Physiol Heart Circ Physiol (2005) 0.88
Superficial femoral artery plaque and functional performance in peripheral arterial disease: walking and leg circulation study (WALCS III). JACC Cardiovasc Imaging (2011) 0.88
Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume. Stroke (2007) 0.87
Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol (2010) 0.87
Task Force 12: training in advanced cardiovascular imaging (cardiovascular magnetic resonance [CMR]) endorsed by the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol (2008) 0.87
Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling. Am J Physiol Heart Circ Physiol (2007) 0.87
CT angiography of the upper extremity arterial system: Part 1-Anatomy, technique, and use in trauma patients. AJR Am J Roentgenol (2013) 0.87
Advances in stress cardiac MRI and computed tomography. Future Cardiol (2013) 0.86
Endoleak detection after endovascular repair of thoracic aortic aneurysm using dual-source dual-energy CT: suitable scanning protocols and potential radiation dose reduction. AJR Am J Roentgenol (2013) 0.86